Clinical Applications of Multi-Omics Integration in Disease Diagnosis

Abstract

The rapid evolution of high-throughput biological technologies has transformed modern medicine, yet the clinical translation of these advances remains fragmented when single-omics approaches are used in isolation. Multi-omics integration, which combines genomic, transcriptomic, proteomic, metabolomic, and epigenomic data, offers a more comprehensive view of disease biology by capturing molecular interactions across multiple biological layers. In clinical settings, this integrative approach has demonstrated growing value in improving diagnostic accuracy, enabling earlier disease detection, and refining patient stratification, particularly for complex and heterogeneous conditions such as cancer, cardiovascular diseases, neurodegenerative disorders, and immune-mediated diseases. By linking molecular signatures to clinical phenotypes, multi-omics frameworks support the identification of robust biomarkers, uncover hidden disease subtypes, and enhance risk prediction beyond conventional diagnostic tools. Advances in bioinformatics, machine learning, and clinical data harmonization have further accelerated the feasibility of translating multi-omics insights into routine diagnostics. However, challenges remain, including data standardization, interpretability, cost, and ethical considerations related to data privacy and clinical decision-making. This review highlights current clinical applications of multi-omics integration in disease diagnosis, discusses representative case studies, and outlines key barriers and future directions for embedding multi-omics-driven diagnostics into precision medicine and real-world healthcare systems.